3[3]REID R R,TOY N MOGFORD F E,et al.Reduction of hypertrophic scar via retroviral delivery of a dominant negative TGF-βreceptor Ⅱ[J].J Plas Reconstru Aesthet Surg,2007,60(1):64-72.
4[4]MORISHITA R,HIGAKI J,TOMITA N,et a1.Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease[J].Circ Res,1998,82(10):1023-1028.
6[6]KIM C W,SUH S L,SUNG S H,et al.A transcriptional factor decoy against AP-1 suppresses TGF-bate1-induced type I collagen gene expression in cultured keloid fibroblasts[J].J Dermatol Sci,2005,37(1),49-51.
8[8]RAMCHANDRAN R,DHANABAL M,VOLK R,et al.Antiangiogenic activity of restin,NC10 domain of human collagen XV:comparison to endostation[J].Biochem Biophys Res Commun,1999,255(3):735-739.
10[10]CHODON T,SUGIHARA T,IGAWA H H,et al.Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-bate1 can abrogate this resistance[J].Am J Pathol,2000,157(5):1661-1669.
2[1]Linares H A, Larson D L. Early differential diagnosis between hypertrophic and nonhypertrophic healing. J Invest Dermatol, 1974, 62: 514 ～ 516
3[2]Hunt T K. Basic principles of wound healing. J Trauma, 1990, 30(12 suppl): S122 ～ S126
4[3]Matsumoto K, Hashimoto K, Yushikawa K, et al. Marked stimulation of growth factor and motility of human keratinocytes by hepatocyte growth factor. Exp Cell Res, 1992, 196: 114 ～ 120
5[4]Ueki T, Kaneda Y, Tsutsui H, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nature Med, 1999, 5: 222 ～ 230
6[5]Morris D E, Wu L, Zhao L L, et al. Acute and chronic animal model for excessive dermal scarring: quantitative studies. Plast Reconstr Surg, 1997, 100: 674 ～ 681
7[6]Ghahary A, You J, Nedelec B, et al. Collagenase production is lower in post burn hypertrophic scar fibroblast than in normal fibroblasts and is reduced by insulin-like-growth factor-1. J Invest Dermatol, 1996, 106: 476 ～ 481
8[7]Lawrence W T, Banes A J. Plastic surgery research. Clin Plast Surg, 1996, 23: 173 ～ 182
9[8]Krummel T M, Ehrlich H P, Nelson J M, et al. Fetal wounds do not contract in utero. Surg Forum, 1989, 40: 613 ～ 615
10[9]Younai S, Nichter L S, Wellisz T, et al. Modulation of collagen synthesis by transforming growth factor-β in keloid and hypertrophic scar fibroblasts. Ann Plast Surg, 1994, 33: 148 ～ 151
6[5]ALSTER T S.Laser treatment of hypertrophic scars,keloids and,striae[J].Dermatol Clin,1997,15(3):419-429.
7[8]CONOLOGUE T D,NORWOOD C.Treatment of surgical scars with the cryogen-cooled 595nm pulsed dye laser starting on the day of suture removal[J].Dermatol Surg,2006,32(1):13-20.
8[9]ALAM M,PON K,Van LABORDE S,et al.Clinical effect of a single pulsed dye laser treatment of fresh surgical scars[J].Dermatol Surg,2006,32(1):21-25.
9[10]CASSUTO D,EMANUELLI G.Non-ablative scar revision using a long pulsed frequency doubled Nd:YAG laser[J].J Cosmetic Laser Ther,2003,5(3-4):135-139.
10LAPIDOTH M,YAGIMA ODO ME,ODO L M.Novel use of erbium:YAG (2,940 nm) laser for fractional ablative photothermolysis in the treatment of photodamaged facial skin:a pilot study[J].Dermatol Surg,2008,34(8):i048-1053.
